Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regression of experimental iris neovascularization with systemic alpha-interferon

J W Miller1, W G Stinson, J Folkman

  • 1Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston 02114.

Ophthalmology
|January 1, 1993
PubMed
Summary

Systemic alpha-interferon effectively inhibited and regressed iris neovascularization in a primate model. This finding offers a promising new pharmacologic approach for treating neovascular eye diseases without damaging retinal tissue.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.

Journal of immunological methods·2008
Same author

Is oncogene addiction angiogenesis-dependent?

Cold Spring Harbor symposia on quantitative biology·2006
Same author

Endostatin therapy reveals a U-shaped curve for antitumor activity.

Cancer gene therapy·2006
Same author

Long-term remission of Crohn's disease treated with thalidomide: a seminal case report.

Angiogenesis·2003
Same author

Angiogenesis and proteins of the hemostatic system.

Journal of thrombosis and haemostasis : JTH·2003
Same author

The role of angiostatin in the spontaneous bone and prostate cancers of pet dogs.

Biochemical and biophysical research communications·2002

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Pharmacology

Background:

  • Intraocular neovascularization causes vision loss in conditions like diabetic retinopathy and macular degeneration.
  • Current treatments, such as laser photocoagulation, damage healthy retinal tissue.
  • A targeted pharmacologic therapy for new blood vessel growth is needed.

Purpose of the Study:

  • To evaluate the efficacy of systemic alpha-interferon in an experimental model of iris neovascularization.
  • To determine if alpha-interferon can inhibit or reverse the growth of new blood vessels in the eye.

Main Methods:

  • Systemic administration of alpha-interferon to cynomolgus monkeys with documented iris neovascularization.
  • Angiographic and histological assessment of neovascularization in treated and control groups.

Related Experiment Videos

Main Results:

  • Eight out of eight treated eyes showed regression of neovascularization.
  • All three control eyes exhibited progression of neovascularization without treatment.
  • Angiographic and histological evidence confirmed the regression of new vessels.

Conclusions:

  • Systemic alpha-interferon successfully inhibited neovascularization and induced regression of new vessels.
  • This study demonstrates the first controlled, systemic drug treatment targeting neovascular tissue in the eye.
  • Alpha-interferon presents a potential novel therapeutic strategy for neovascular eye diseases.